May 02, 2012 | from New York Times
A Sharp Rise in Scientific Journal Retractions
NYT Reports scientific retractions are on the rise because of a "dysfunctional scientific climate" that has created a "winner-take-all game with perverse incentives that lead scientists to cut corners and, in some cases, commit acts of misconduct".
May 02, 2012 | from
Georgetown University Medical Center PharmedOut Annual Conferance
PharmedOut announces its third annual conference, Missing The Target: When Practitioners Harm More Than Heal, to be held on June 14th and 15th, 2012 at Georgetown University.
March 31, 2012 | from NEJM
Industry Support of CME Are We at the Tipping Point?
Although industry support for accredited CME is unlikely to disappear entirely in the near future, a sea change toward greater restriction is beginning to happen as a result of cultural, regulatory, and economic changes and a few courageous acts. CME and health care will be better for it.
March 03, 2012 | from
March 8th Release of the 2011-2012 AMSA PharmFree Scorecard
On Thursday, March 8, 2012, the American Medical Student Association (AMSA) will release the 2011-2012 AMSA PharmFree Scorecard, an evaluation of conflict-of-interest policies at all U.S. medical colleges and colleges of osteopathic medicine.
March 02, 2012 | from Community Catalyst
Consumers Call for Maximum Sunshine - and Soon
AMSA and 18 other consumer, patient safety and labor groups weighed in last week in support of draft regulations issued by the Centers for Medicare and Medicaid Services (CMS) requiring that the drug, biologics and medical device industries publicly report all payments to physicians and teaching hospitals
March 02, 2012 | from
Medical student questions doctors being paid by drug companies
KATU News On Your Side investigation which features Lee Shapley PharmFree Scorecard Director and Oregon Health and Science University Medical Student
March 02, 2012 | from Washington Post
The world's most boring journal and why it's good for science
The Journal of Negative Results in BioMedicine (JNRBM). Published, presumably, by a gang of dour curmudgeons who hate everything, JNRBM openly welcomes the data that other journals will not touch because it does not fit the unspoken rule that all articles must end on a cheery note of promise.
February 28, 2012 | from Slate
Scientists Achieve Victory Over Research Works Act
Reps Maloney and Issa backtrack. Elseveir withdraws support for Research Works Act
February 11, 2012 | from
AMSA and 6 Groups write to oppose the "Research Works Act"
On February 8, 2012, seven public health organisations submitted a letter to the Committee on Oversight and Government Reform opposing H.R. 3699, the "Research Works Act." This bill would prohibit federal agencies from conditioning its federal grants on recipients making its published research results available to the public.
February 11, 2012 | from FDA Press Release
FDA issues draft guidance on biosimilar product development
The U.S. Food and Drug Administration today issued three draft guidance documents on biosimilar product development to assist industry in developing such products in the United States.